Related Experiment Video

Updated: May 27, 2026

Murine Isolated Heart Model of Myocardial Stunning Associated with Cardioplegic Arrest
08:30

Murine Isolated Heart Model of Myocardial Stunning Associated with Cardioplegic Arrest

Published on: August 6, 2015

Takotsubo cardiomyopathy or broken heart syndrome: A review article

Allahyar Golabchi1, Nizal Sarrafzadegan

  • 1Resident of Cardiology, School of Medicine, Isfahan University of Medical Science, Isfahan, Iran.

Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences
|November 18, 2011
PubMed

Insights

Stress-induced cardiomyopathy, also known as Takotsubo cardiomyopathy, is a heart condition with temporary left ventricular dysfunction. It mimics heart attacks but lacks coronary blockages, requiring distinct medical management strategies.

Area of Science:

  • Cardiology
  • Internal Medicine

Background:

  • Stress-induced cardiomyopathy (Takotsubo cardiomyopathy) is increasingly diagnosed.
  • It presents as transient left ventricular dilation and dysfunction.
  • It shares features with acute myocardial infarction but lacks coronary artery stenosis.

Purpose of the Study:

  • To highlight the pathophysiology, diagnosis, and treatment of Takotsubo cardiomyopathy.
  • To differentiate it from acute myocardial infarction.
  • To inform physicians about its unique management.

Main Methods:

  • Review of clinical presentation.
  • Diagnostic criteria analysis.
  • Comparison with acute myocardial infarction.

Main Results:

  • Takotsubo cardiomyopathy involves temporary apical or mid-left ventricular dysfunction.
  • Absence of significant coronary artery stenosis and intracoronary thrombi is a key differentiator.
  • Management strategies differ significantly from acute myocardial infarction.

Conclusions:

  • Physicians must recognize the distinct pathophysiology of Takotsubo cardiomyopathy.
  • Accurate diagnosis is crucial for appropriate patient management.
  • Understanding these differences ensures optimal treatment and patient outcomes.

Keywords:
Ampulla cardiomyopathyApical ballooning syndromeBroken heart syndromeStress induced cardiomyopathyTakotsubo cardiomyopathy

More Related Videos

Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy07:02

Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy

Published on: September 9, 2020

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...